The Horseracing Integrity and Safety Authority (HISA) has announced the members of its Horsemen's Advisory Group, who were selected from among the more than 250 applications received from hands-on racing participants from across the country. Starting in November, the Advisory Group will convene on a monthly basis to provide feedback to the Authority's executive team and Standing Committees on the implementation and evolution of HISA's Racetrack Safety and Anti-Doping and Medication Control regulations. Members will serve between 1-2-year terms to stagger changes in the composition of the group and to maximize the opportunity for participation across the industry in the coming years.
“I want to thank everyone across the horseracing community who expressed interest in joining the Horsemen's Advisory Group. I am particularly grateful to its distinguished and highly qualified new members who have agreed to collaborate with us on an ongoing basis,” said Lisa Lazarus, HISA CEO. “I know that HISA will benefit immensely from this group's extensive, hands-on experience in Thoroughbred racing as we continue to work with all industry stakeholders to advance the safety and integrity of our sport.”
The following individuals have been selected to serve as members of the inaugural Horsemen's Advisory Group:
The post HISA Announces Membership of Horsemen’s Advisory Group appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
Dr. Jeff Blea has returned to his position as the equine medical director for the California Horse Racing Board after a controversial eight-month suspension enforced by the California Veterinary Medical Board (VMB), but according to the Thoroughbred Daily News, controversy remains between the VMB and backstretch veterinary practitioners across the state.
The complaints against Blea and other backstretch veterinarians have been “very unusual,” American Association of Equine Practitioners (AAEP) executive director David Foley told the TDN.
“If the veterinary medical board is going to interpret the rules in a companion animal manner towards equine practitioners, nobody's going to want to practice in California,” Foley said.
In January's meeting of the VMB, Dan Baxter, executive director of the California Veterinary Medical Association (CVMA), voiced the organization's concern about whether VMB regulations are in touch with business practices: “We fear that there may be a significant disconnect between the reasonable, sound practice standards observed by equine practitioners in the field and the standards to which those same practitioners are being held by the board.”
Despite ongoing meetings between the VMB's two-person Equine Practice Subcommittee, the CVMA, and the CHRB, there remains little clarity for or licensed backstretch practitioners.
Among the primary discrepancies is the use of compounded medications.
CHRB Rule 1867 (b) states that “the possession and/or use on the premises of a facility under the jurisdiction of the Board of any drug, substance or medication that has not been approved by the United States Food and Drug Administration (FDA) for use in the United States.” The CHRB's “longstanding interpretation” of rule 1867 “is that lawfully prescribed, compounded medications which are manufactured according to Federal and State guidelines do not violate this regulation.”
Conversely, the VMB interprets the rule to prohibit the use of compounded drugs entirely, even those compounded from FDA-approved parent drugs.
Monica Vargas, spokesperson for the VMB, told the TDN that while the VMB “cannot advise on CHRB enforcement of laws applicable to their licensees,” the VMB has jurisdiction over the practice of veterinary medicine in California “unless otherwise pre-empted.” Pre-emption could come in the form of the federally-enacted Horseracing Integrity and Safety Act, but HISA has not yet involved itself in the dispute and those practitioners already facing complaints remain stranded.
Read more at the Thoroughbred Daily News.
The post ‘Nobody’s Going To Want To Practice In California’: Backstretch Veterinary Regulations Remain Unclear In Wake Of Blea Investigation appeared first on Horse Racing News | Paulick Report.
Observations on the European Racing Scene turns the spotlight on the best European races of the day, highlighting well-pedigreed horses early in their careers, horses of note returning to action and young runners that achieved notable results in the sales ring. Tuesday's Insights features a son of MGSW Prize Exhibit (GB).
1.25 Yarmouth, Novice, £9,950, 2yo, f, 8f 3yT
BRIDESTONES (IRE) (Teofilo {Ire}) debuts for Godolphin and John and Thady Gosden and is a daughter of the operation's G1 Fillies' Mile and G2 May Hill S. heroine White Moonstone (Dynaformer). Related to the Breeders' Cup Sprint winner Desert Stormer (Storm Cat), the March-foaled bay encounters nine peers on a tough introduction.
2.00 Gowran Park, Mdn, €16,000, 2yo, 8f 75yT
JOAQUIN SOROLLA (IRE) (Galileo {Ire}) debuts for a Balldoyle stable going from strength-to-strength with its juveniles and is a particularly fascinating prospect as a son of the multiple graded-stakes scorer Prize Exhibit (GB) (Showcasing (GB}) whose group 3-winning 3-year-old daughter History (Ire) also by Galileo cost 2.8million gns when selling at the 2020 Book 1. A full-sister to the G1 Sussex S. hero Mohaather (GB), her February-foaled bay is one of a trio from the yard including the Tipperary fifth San Antonio (Ire) (Dubawi {Ire}), a son of the Irish Oaks runner-up Rain Goddess (Ire) (Galileo {Ire}).
The post Observations: Son of Prize Exhibit Debuts at Gowran appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
